Mizuho Maintains Buy on Encompass Health, Raises Price Target to $77
Portfolio Pulse from jenniferd'souza@benzinga.com
Mizuho analyst Ann Hynes maintains a 'Buy' rating on Encompass Health (NYSE:EHC) and raises the price target from $74 to $77.
August 04, 2023 | 1:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Encompass Health's price target has been raised from $74 to $77 by Mizuho, maintaining a 'Buy' rating.
The raised price target and maintained 'Buy' rating by Mizuho indicates a positive outlook for Encompass Health. This could potentially lead to an increase in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100